PanGen Biotech Inc. (KOSDAQ: 222110)
South Korea
· Delayed Price · Currency is KRW
4,470.00
-210.00 (-4.49%)
Oct 11, 2024, 9:00 AM KST
PanGen Biotech Revenue
PanGen Biotech had revenue of 2.27B KRW in the quarter ending June 30, 2024, with 90.13% growth. This brings the company's revenue in the last twelve months to 11.13B, up 128.91% year-over-year. In the year 2023, PanGen Biotech had annual revenue of 7.32B with 12.53% growth.
Revenue (ttm)
11.13B
Revenue Growth
+128.91%
P/S Ratio
4.37
Revenue / Employee
n/a
Employees
n/a
Market Cap
51.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.32B | 814.47M | 12.53% |
Dec 31, 2022 | 6.50B | -1.43B | -18.08% |
Dec 31, 2021 | 7.94B | 1.74B | 28.18% |
Dec 31, 2020 | 6.19B | 3.31B | 114.87% |
Dec 31, 2019 | 2.88B | -2.80B | -49.27% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition